Zenith continues to support the global movement of breast cancer awareness by creating a unique DEFY Midnight for Pink Ribbon Switzerland’s annual charity auction.
On October 30, 2021, at the prestigious Dolder Grand Hotel overlooking Zürich, Pink Ribbon Switzerland – a charitable organization that spreads awareness about the disease and the importance of early detection through various activities and fundraising initiatives – will host its annual music gala with a charity auction where a unique Zenith DEFY Midnight will be offered for sale.
This year, the 11th annual Pink Ribbon breast cancer gala will take place at the Dolder Grand Hotel, where guests can look forward to an evening full of culinary delights and emotional highlights. Numerous Swiss artists and personalities will be joining, with presenter Sven Epiney hosting the evening’s various activities. An auction will be held during the gala dinner, where several one-off items will be sold to help finance breast cancer studies for young patients of the “International Breast Cancer Study Group”, one of the few research projects that focuses on early detection of breast cancer in a younger demographic of women. Among the lots in the auction is a truly exceptional piece of watchmaking for the modern, confident woman that forges her own path in life. The Zenith DEFY Midnight Pink Ribbon edition is a unique piece created exclusively for the Pink Ribbon gala.
The model, which comes in a 36mm diameter steel case, hosts a bright pink dial with a vertical gradient effect. The pink theme on the dial, which is enriched with stars and diamond hour markers, is complemented by 44 pink sapphires set on the bezel.
The Pink Ribbon unique piece comes with a steel bracelet as well as a white rubber strap with pink leather and a black rubber strap with a velvet effect.
With the donation of this unique piece and its continued support of Pink Ribbon Switzerland, Zenith stands in solidarity with women in the face of breast cancer by spreading awareness and raising funds to promote early detection and develop new treatments.
